LncRNA DLX6-AS1 promotes necroptosis through PI3K/AKT/mTOR signaling pathway in myocardial ischemia/reperfusion injury mice
What this study shows
LncRNA DLX6-AS1 activates PI3K/AKT/mTOR signaling to promote necroptosis in myocardial ischemia-reperfusion injury; inhibiting DLX6-AS1 suppresses necroptosis and protects cardiomyocytes.
At a glance
| Evidence type | A Animal model Marked A because it is an animal intervention or observation study measuring an organismal outcome (model: Mouse; Rat H9c2 cells); the code names the system studied -- animal work can be rigorous and still not be human data. |
| Study type | 4 - Animal Study |
| Model system | Mouse; Rat H9c2 cells |
| Journal | Scientific Reports |
| Year | 2026 |
| Peer reviewed | Yes |
| Record last updated | 2026-10-01 |
| Source | DOI 10.1038/s41598-026-50371-y · PMID 42601357 · Free full text (PMC13476243) |
Extracted findings
These fields were extracted from the paper with AI assistance and have not been checked against the source. Read them as a pointer into the paper, not as curated claims; where they disagree with the curated summary above, the curated summary stands.
| Intervention | DLX6-AS1 overexpression/inhibition |
| Target | PI3K/AKT/mTOR pathway; RIP1; RIP3; MLKL |
| Model | Mouse; Rat |
| Effect | DLX6-AS1 activates PI3K/AKT/mTOR, promoting necroptosis in cardiac I/R injury; knockdown is cardioprotective |
In the Atlas
Related topics
More studies on this topic
- The phosphoinositide 3-kinase pathway (2002)
- IGF2BP3-Mediated m6A Modification of OLR1 mRNA Promotes Immune Evasion in CRC via the PI3K/AKT/mTOR Pathway (2026)
- A dynamic network model of mTOR signaling reveals TSC-independent mTORC2 regulation (2012)
- Evidence for direct activation of mTORC2 kinase activity by phosphatidylinositol 3,4,5-trisphosphate (2011)
Was this page useful?
Thank you. Your answer was counted anonymously.